
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL... Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.74 | -0.261059761518 | 283.46 | 303.445 | 277.5 | 323945 | 291.31118692 | CS |
4 | -6.81 | -2.35208786654 | 289.53 | 303.445 | 265 | 311181 | 279.80287077 | CS |
12 | -59.99 | -17.5045957223 | 342.71 | 349 | 265 | 336023 | 302.08075182 | CS |
26 | -23.58 | -7.69833496572 | 306.3 | 377.46 | 265 | 369035 | 313.9305896 | CS |
52 | 5.84 | 2.10921698931 | 276.88 | 377.46 | 200.63 | 358584 | 295.46699454 | CS |
156 | 211.06 | 294.529723695 | 71.66 | 377.46 | 57.21 | 399040 | 232.81685025 | CS |
260 | 171.96 | 155.25460455 | 110.76 | 377.46 | 52.33 | 302900 | 204.10926656 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions